Filter
175
Filtered Results: 175
Text search:
buruli
ulcer
Featured
Recommendations
21
New Publications
25
Language
Document type
No document type
51
Studies & Reports
43
Guidelines
25
Strategic & Response Plan
13
Manuals
11
Brochures
7
Videos
7
Fact sheets
6
Resource Platforms
5
Training Material
3
Infographics
3
Online Courses
1
Countries / Regions
Global
20
Liberia
6
Ghana
6
Nigeria
4
Africa
3
Sierra Leone
2
Congo, Democratic Republic of
2
Saudi Arabia
2
Pakistan
2
Iraq
2
Jordan
2
Germany
2
Lebanon
2
Syria
2
Sudan
2
Benin
2
Western and Central Europe
2
Iran
2
Burkina Faso
1
Morocco
1
Cameroon
1
Uganda
1
Togo
1
Somalia
1
Afghanistan
1
Egypt
1
Kenya
1
Malawi
1
Ecuador
1
Greece
1
Libya
1
Yemen
1
Middle East and North Africa
1
Palestine
1
Albania
1
Djibouti
1
Qatar
1
Georgia
1
Tunisia
1
Authors & Publishers
Publication Years
Category
Clinical Guidelines
48
Countries
33
Public Health
10
Capacity Building
6
Pharmacy & Technologies
5
Key Resources
2
Women & Child Health
1
Toolboxes
NTDs
95
TB
11
Rapid Response
6
Caregiver
3
Ebola
2
Planetary Health
2
NCDs
2
Disability
1
Natural Hazards
1
Refugee
1
HIV
1
Global Health Education
1
AMR
1
COVID-19
1
Pharmacy
1
The World Health Organization (WHO) convened a meeting of the Technical Advisory Group on Buruli ulcer at its headquarters in Geneva, Switzerland on 25 to 27 March 2019
The meeting was held from 26 to 27 March 2018 to review and discuss the following topics:
Advances and challenges in the use of fTLC, and new approaches to detecting mycolactone using monoclonal antibodies (mAbs).
The status of development of rapid diagnostic tests (RDTs) targeting the MUL...
Volume 2016 | Article ID 5310718 | https://doi.org/10.1155/2016/5310718. Buruli ulcer (BU) is a necrotizing cutaneous infection caused by Mycobacterium ul...ans. Early diagnosis is crucial to prevent morbid effects and misuse of drugs. We review developments in laboratory diagnosis of BU, discuss limitations of available diagnostic methods, and give a perspective on the potential of using aptamers as point-of-care.
This manual is to assist health care providers and laboratory scientists to diagnose mycobacterium ulcerans disease (Buruli ulcer). The manual aims...
Buruli ulcer : management of Mycobacterium ulcerans disease : a manual for health care providers
recommended
This manual is addressed to health care providers dealing with Mycobacterium ulcerans disease (Buruli ulcer). The manual aims to achieve a better u...
The purpose of this book is to provide an overview of Buruli ulcer (Mycobacterium ulcerans infection) for the medical and scientific communities an...
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 25, No. 12, December 2019 2183
Buruli ulcer is a neglected tropical disease caused by Myocobacterium ...ans; it manifests as a skin lesion, nodule, or ulcer that can be extensive and disabling. To assess the global burden and the progress on disease control, we analyzed epidemiologic data reported by countries to the World Health Organization during 2010–2017.
Cotonou declaration on buruli ulcer
recommended
Cotonou Declaration oBuruli Ulcer
Cotonou, Benin, 30 March 2009
Neglected tropical diseases kill, weaken or incapacitate millions of people every year, causing permanent physical suffering, social stigmatization and reduced productive capacity. ... ulcer, one such disease, causes immense suffering and disabilities, especially among children. Delayed schooling and loss of productivity are considerable among the affected populations. These adverse consequences tend to aggravate poverty in affected communities. Globally, the disease has been reported in 30 countries. In WHO’s African Region, Buruli ulcer has been confirmed in 12 countries and is suspected in 10 others.
Significant progress has been made in the past 10 years in knowledge of Buruli
ulcer, investments in related research, control of the disease, and improvement
of tools for case diagnosis and development of treatment protocols. Substantial achievements have been made in diagnosis, treatment, immunology and epidemiology. Despite these achievements, little is known about the exact mode of transmission of the disease, and there is no simple diagnostic test usable in the field.
The use of antibiotics has revolutionized treatment and contributed to reducing the need for surgery by half. However, efforts are still needed to develop simple diagnostic tools usable in the field as well as disability prevention methods. The Global Buruli Ulcer Initiative has adopted the strategy recommended by WHO. The strategy is based on early diagnosis of the disease and the use of antibiotics for treatment upon the onset of the first signs by improving access to screening and case management at the most peripheral level of the health system.
Buruli ulcer – community information sheet (October 2018)
Buruli ulcer (Mycobacterium ulcerans infection) Resource platform
Information sheet Buruli Ulcer
Prevention of disability in Buruli ulcer through health education and self-care training
Prevention of disability in Buruli ulcer
Learn how to identify and treat the disease early.
Learn how to prevent disability.
Disability Prevention. Informational manual for
Buruli ulcer caused by Mycobacterium ulcerans is a neglected tropical disease characterized by extensive ...ation involving predominantly the upper and lower limbs of patients. The disease is common in rural tropical communities in West and Central Africa, where access to proper health care is limited. Pathogenesis of the characteristic painless ulcers is linked to the elaboration by M. ulcerans of a lipid toxin called mycolactone that has potent cytopathic, immunosuppressive, and analgesic effects on a host of cells in cutaneous tissues. Mycolactone is known to profoundly inhibit secretion of a plethora of proteins that are essential for wound healing. Even though a combination antibacterial therapy of streptomycin and rifampicin for 8 weeks is effective for treatment, it relies on good and appropriate wound management to prevent secondary bacterial infections and improve healing. Evidence-based interventions for wound care in Buruli ulcer disease are often lacking and have relied on expert advice and recommendations. Surgical interventions are limited to debridement of necrotic tissue and grafting of extensive ulcers, usually after antibiotic therapy. Patients’ rehabilitation is an important component of care to reduce disabilities associated with the disease and proper integration into the community after treatment.
This video "Buruli Ulcer Disease: Intro to the Module" is part of a multimedia-based module by Richard Phillips, Stephen Sarfo, Emmanuel Adu, Veronica Owusu-Afriyie, and Cary Engleberg (University o...
Buruli Ulcer, buruli ulcer signs and symptoms, burul... ulcer treatment, Buruli ulcer risks, Buruli ulcer disease, health care workers and buruli ulcer
Nat Commun 9, 5370 (2018). https://doi.org/10.1038/s41467-018-07804-8. Mycobacterium ulcerans is the causative agent of Buruli ulcer, a neglected t...
